Trial intelligence / Profile preview

Mitoxantrone With or Without Docetaxel in Metastatic Breast Cancer

NCT00002544Phase 3Completed

Sponsor
Arbeitsgemeinschaft Internistische Onkologie
Start
May 1993
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of docetaxel in breast cancer, sponsored by Arbeitsgemeinschaft Internistische Onkologie. Started May 1993; status: completed.

02

Drugs

docetaxel
03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT00002544.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00002544.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call